 "Sun Pharma")
Pharma major Sun Pharma on Monday reported a surprise consolidated net loss of Rs 2,277 crore for the quarter ending March 31, 2022. It reported consolidated net profit of Rs 848 crore in the year-ago period.
Total loss cited as an exceptional item during the fourth quarter, stood at Rs 3,936 crore. During the quarter and year ended March 2022, the company said its unit Taro Pharmaceutical Industries has acquired Alchemee, formerly The Proactiv Company (TPC), from Galderma. Accordingly, the results for the quarter and year ended March 2022 are not comparable to the earlier periods presented, it added.
Sun Pharma's consolidated
